Zoetis’s Q4 2024 earnings reveal a strong performance in the companion animal segment with 14% growth, while the livestock portfolio faces challenges. Strategic initiatives position the company for future growth.
Zoetis Inc. (NYSE: ZTS) showcases remarkable growth in Q3 2024 with a revenue of $2.4 billion. The company’s dominance in the animal health sector is backed by innovative products and strategic advancements across companion and livestock segments.
